SCHEMBL30457623

SCHEMBL30457623

O=C1CC(=O)N(c2ccccc2F)C(=S)N1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.77
KMT2A Q03164 11/20 0.77
MAPT P10636 7/20 0.50
LMNA P02545 3/20 0.49
MGLL Q99685 1/20 0.47
HPGD P15428 3/20 0.46
ALDH1A1 P00352 2/20 0.46
PKM P14618 2/20 0.46
MCL1 Q07820 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
THRB P10828 2/20 0.46
RECQL P46063 2/20 0.46
HTT P42858 2/20 0.46
POLB P06746 3/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30457791 0.83 MEN1 (0.54) MEN1KMT2AMAPTLMNAHPGD
SCHEMBL28494976 0.78 KMT2A (0.58) MEN1KMT2AMAPTLMNAMGLL
SCHEMBL123633 0.78 GRK5 (0.56) MEN1KMT2AMAPTLMNAHPGD
SCHEMBL25277766 0.77 GAA (0.55) MEN1KMT2AMAPTLMNAMGLL
SCHEMBL30457532 0.74 MAPT (0.56) MEN1KMT2AMAPTMGLLALDH1A1
SCHEMBL7008036 0.73 HPGD (0.62) MEN1KMT2AMAPTMGLLHPGD
SCHEMBL28933339 0.71 KMT2A (0.61) MEN1KMT2AMAPTMGLLHPGD
SCHEMBL124716 0.69 MAPT (0.73) MEN1KMT2AMAPTLMNAMGLL
SCHEMBL9795662 0.69 KMT2A (0.51) MEN1KMT2AMAPTLMNAMGLL
SCHEMBL149619 0.69 MEN1 (0.52) MEN1KMT2AMAPTPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING PARIS SCIENCES ET LETTRES (FR) 2025-02-13 US disclosed
EP-4444308-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING Institut Curie (FR) 2024-10-16 EP disclosed
WO-2023104976-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING INSTITUT CURIE (FR) 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING STAT1, IFNG, IRF2BP2 MEN1 3227/4885KMT2A 2840/4885MAPT 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.